Stay updated on ARV-471 Combo vs Letrozole Combo in Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the ARV-471 Combo vs Letrozole Combo in Breast Cancer Clinical Trial page.

Latest updates to the ARV-471 Combo vs Letrozole Combo in Breast Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision: v3.5.2 is now displayed, replacing Revision: v3.5.0; this appears to be a backend or UI version update with no changes to study content.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check33 days agoChange DetectedAdded Naples, Campania, Italy, 80131 and removed Napoli, Campania, Italy, 80131.SummaryDifference0.0%

- Check40 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3 (page revision metadata).SummaryDifference0.0%

- Check47 days agoChange DetectedThe page now displays Revision 3.4.3, replacing Revision 3.4.2.SummaryDifference0.0%

- Check76 days agoChange DetectedAdded VERITAC-3 study details including design, SLI and Phase 3 plan, enrollment targets, endpoints, and participating locations. Removed outdated notices about funding and prior version text.SummaryDifference1%

- Check83 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and NIH operating status, with links to cc.nih.gov and opm.gov for updates. Updated the page revision to v3.4.1 (replacing v3.4.0).SummaryDifference0.3%

Stay in the know with updates to ARV-471 Combo vs Letrozole Combo in Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ARV-471 Combo vs Letrozole Combo in Breast Cancer Clinical Trial page.